Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Kern

Concepts (290)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
25
2024
2342
2.480
 Why?
Receptor, ErbB-2
14
2019
325
2.440
 Why?
Neuregulin-1
9
2019
46
2.370
 Why?
Carcinoma, Non-Small-Cell Lung
17
2024
1050
1.720
 Why?
Lung
13
2019
3928
1.480
 Why?
Signal Transduction
10
2019
4916
1.120
 Why?
Respiratory Mucosa
4
2014
310
1.040
 Why?
Antineoplastic Agents, Immunological
3
2022
181
0.920
 Why?
Acute Lung Injury
3
2012
280
0.900
 Why?
Radiosurgery
2
2024
321
0.860
 Why?
Pneumonectomy
1
2024
151
0.780
 Why?
ErbB Receptors
7
2014
605
0.770
 Why?
Receptor, ErbB-3
6
2007
44
0.690
 Why?
Epithelium
2
2019
311
0.660
 Why?
Protein-Tyrosine Kinases
2
2019
431
0.660
 Why?
Adult Stem Cells
1
2019
39
0.630
 Why?
Small Cell Lung Carcinoma
1
2020
88
0.620
 Why?
Alveolar Epithelial Cells
1
2019
107
0.600
 Why?
Adenocarcinoma
5
2019
889
0.590
 Why?
Neuroendocrine Cells
2
2016
31
0.590
 Why?
Immunotherapy
2
2022
596
0.550
 Why?
Cell Transformation, Neoplastic
1
2019
318
0.550
 Why?
Tomography, X-Ray Computed
7
2015
2503
0.530
 Why?
Neoplasm Staging
8
2024
1281
0.530
 Why?
Neoplasm Proteins
1
2019
417
0.510
 Why?
STAT3 Transcription Factor
5
2009
194
0.470
 Why?
Interleukin-6
1
2019
724
0.470
 Why?
Adherens Junctions
1
2014
25
0.460
 Why?
B-Lymphocyte Subsets
1
2014
74
0.420
 Why?
Immunity, Humoral
1
2014
118
0.410
 Why?
Cell Adhesion
1
2014
454
0.410
 Why?
beta Catenin
1
2014
224
0.400
 Why?
Carcinoma, Squamous Cell
4
2019
628
0.390
 Why?
Pulmonary Fibrosis
2
2007
385
0.390
 Why?
Epithelial Cells
3
2011
1061
0.390
 Why?
Quality of Life
1
2024
2694
0.390
 Why?
Blood Coagulation Factors
1
2012
53
0.380
 Why?
Protein C
1
2012
47
0.380
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2012
19
0.380
 Why?
Smad3 Protein
1
2011
43
0.360
 Why?
Smad2 Protein
1
2011
38
0.360
 Why?
Trans-Activators
2
2004
392
0.350
 Why?
Neoplasms
3
2024
2450
0.340
 Why?
Transforming Growth Factor beta1
1
2011
158
0.340
 Why?
Receptors, Cell Surface
1
2012
381
0.330
 Why?
p38 Mitogen-Activated Protein Kinases
1
2011
277
0.330
 Why?
Bronchoalveolar Lavage Fluid
1
2012
646
0.320
 Why?
Lung Diseases
2
2016
741
0.310
 Why?
Epithelial-Mesenchymal Transition
1
2011
201
0.310
 Why?
Humans
46
2024
129527
0.310
 Why?
Early Detection of Cancer
1
2013
371
0.310
 Why?
Permeability
4
2014
158
0.300
 Why?
Quinazolines
5
2014
241
0.300
 Why?
Phosphorylation
6
2019
1714
0.290
 Why?
Prenylation
1
2008
3
0.290
 Why?
Antibodies, Monoclonal
5
2007
1366
0.290
 Why?
Protein Kinase Inhibitors
4
2014
885
0.250
 Why?
Piperidines
1
2008
200
0.250
 Why?
DNA-Binding Proteins
2
2004
1438
0.250
 Why?
Tomography, Emission-Computed
2
2003
66
0.250
 Why?
Epidermal Growth Factor
3
2012
170
0.230
 Why?
Drug Eruptions
2
2024
27
0.230
 Why?
Pyridines
1
2008
478
0.220
 Why?
Autocrine Communication
1
2004
41
0.220
 Why?
Mass Screening
1
2012
1186
0.220
 Why?
Thoracic Surgery, Video-Assisted
1
2024
43
0.220
 Why?
Morphogenesis
1
2004
158
0.210
 Why?
Mediastinal Neoplasms
1
2003
39
0.210
 Why?
Enzyme Inhibitors
2
2004
825
0.210
 Why?
Cell Line, Tumor
6
2019
3181
0.200
 Why?
Skin Diseases
2
2024
143
0.200
 Why?
Genetic Therapy
1
2005
286
0.200
 Why?
Milk Proteins
1
2002
34
0.200
 Why?
Phosphatidylinositol 3-Kinases
1
2004
353
0.190
 Why?
Aged, 80 and over
8
2024
7052
0.190
 Why?
Cisplatin
2
2020
298
0.190
 Why?
Cell Line
4
2014
2774
0.190
 Why?
ADAM17 Protein
2
2012
33
0.190
 Why?
Cell Proliferation
4
2015
2367
0.190
 Why?
Radiopharmaceuticals
1
2002
167
0.180
 Why?
Fluorodeoxyglucose F18
1
2002
128
0.180
 Why?
ADAM Proteins
2
2012
59
0.180
 Why?
Animals
10
2021
35334
0.180
 Why?
RNA Interference
2
2014
450
0.180
 Why?
CTLA-4 Antigen
1
2021
87
0.170
 Why?
Recombinant Proteins
3
2011
1311
0.170
 Why?
Female
15
2024
68650
0.170
 Why?
Etoposide
1
2020
148
0.160
 Why?
Enzyme Induction
1
2019
90
0.160
 Why?
RNA, Neoplasm
1
2019
82
0.160
 Why?
Tight Junctions
2
2014
75
0.160
 Why?
Receptors, Interleukin-6
1
2019
37
0.160
 Why?
Antigens
1
2021
356
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2021
232
0.150
 Why?
Cells, Cultured
3
2019
4087
0.150
 Why?
B7-H1 Antigen
1
2021
198
0.150
 Why?
Sirolimus
1
2020
270
0.150
 Why?
Enzyme Activation
2
2014
806
0.150
 Why?
Transfection
3
2011
916
0.150
 Why?
Male
14
2024
63586
0.140
 Why?
Hyperplasia
2
2016
175
0.140
 Why?
Cell Lineage
1
2019
332
0.140
 Why?
Mice
6
2019
16973
0.140
 Why?
Middle Aged
9
2024
31087
0.140
 Why?
RNA, Messenger
3
2019
2697
0.140
 Why?
Xenograft Model Antitumor Assays
1
2020
804
0.140
 Why?
TOR Serine-Threonine Kinases
1
2020
393
0.140
 Why?
Aged
8
2024
22063
0.130
 Why?
Longitudinal Studies
1
2024
2724
0.130
 Why?
Immunosuppressive Agents
1
2021
858
0.130
 Why?
Antigen Presentation
1
2017
207
0.130
 Why?
Cytokines
1
2024
2018
0.130
 Why?
Lung Diseases, Obstructive
1
2016
46
0.130
 Why?
Treatment Outcome
4
2024
10232
0.130
 Why?
Tumor Cells, Cultured
4
2013
931
0.120
 Why?
Mutation
4
2014
3702
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2013
952
0.120
 Why?
Neoplastic Stem Cells
1
2019
378
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
204
0.120
 Why?
Research Report
1
2016
79
0.120
 Why?
Drug Synergism
2
2008
370
0.120
 Why?
Multiple Pulmonary Nodules
1
2015
19
0.120
 Why?
Bleomycin
2
2007
243
0.120
 Why?
Electric Impedance
1
2014
102
0.110
 Why?
ral GTP-Binding Proteins
1
2013
5
0.110
 Why?
Bronchiolitis
1
2015
90
0.110
 Why?
Tyrphostins
2
2004
17
0.110
 Why?
Medical Oncology
1
2016
267
0.100
 Why?
Transcriptome
1
2019
875
0.100
 Why?
Forced Expiratory Volume
1
2015
508
0.100
 Why?
Protein Binding
1
2019
2121
0.100
 Why?
ras Proteins
1
2013
143
0.100
 Why?
Time Factors
3
2011
6530
0.100
 Why?
T-Lymphocytes
1
2021
1935
0.100
 Why?
Blotting, Western
3
2013
1199
0.100
 Why?
Radiography, Thoracic
1
2013
165
0.100
 Why?
RNA, Small Interfering
1
2014
590
0.100
 Why?
History, 20th Century
1
2013
295
0.100
 Why?
B-Lymphocytes
1
2017
816
0.100
 Why?
Tomography, Spiral Computed
1
2011
27
0.090
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
147
0.090
 Why?
Cell Division
2
2004
787
0.090
 Why?
Cell Shape
1
2011
56
0.090
 Why?
Biopsy, Needle
1
2011
187
0.090
 Why?
CD4-Positive T-Lymphocytes
1
2017
1058
0.090
 Why?
Blood-Air Barrier
1
2011
10
0.090
 Why?
Collagen Type I
1
2011
118
0.090
 Why?
Fibronectins
1
2011
126
0.090
 Why?
Survival Rate
4
2013
1870
0.090
 Why?
Cellular Senescence
1
2012
173
0.090
 Why?
Bronchoscopy
1
2011
219
0.080
 Why?
Proto-Oncogene Proteins
1
2013
632
0.080
 Why?
Protein Inhibitors of Activated STAT
1
2009
6
0.080
 Why?
Cadherins
1
2011
187
0.080
 Why?
Vena Cava, Superior
1
2009
22
0.080
 Why?
Coronary Vessel Anomalies
1
2009
33
0.080
 Why?
Pulmonary Alveoli
1
2012
403
0.080
 Why?
Disease Models, Animal
2
2011
4073
0.080
 Why?
Global Health
1
2011
328
0.080
 Why?
Transcriptional Activation
1
2011
366
0.080
 Why?
Asthma
1
2022
2225
0.080
 Why?
Interleukin-1beta
1
2011
368
0.080
 Why?
Delivery of Health Care
1
2016
896
0.080
 Why?
Antigens, CD
1
2011
485
0.070
 Why?
Electronic Health Records
1
2016
977
0.070
 Why?
Colorimetry
1
2008
11
0.070
 Why?
Occupational Exposure
1
2011
302
0.070
 Why?
Oncogene Protein v-akt
1
2008
24
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2008
66
0.070
 Why?
Molecular Chaperones
1
2009
181
0.070
 Why?
Abnormalities, Multiple
1
2009
174
0.070
 Why?
Mesothelioma
1
2008
38
0.070
 Why?
Indicators and Reagents
1
2008
108
0.070
 Why?
Respiration, Artificial
1
2012
615
0.070
 Why?
Antimetabolites, Antineoplastic
1
2008
91
0.070
 Why?
Azacitidine
1
2008
137
0.070
 Why?
Pulmonary Disease, Chronic Obstructive
2
2012
998
0.070
 Why?
Comorbidity
1
2011
1548
0.070
 Why?
Contrast Media
1
2009
393
0.070
 Why?
Randomized Controlled Trials as Topic
1
2012
1368
0.060
 Why?
Nitrates
1
2006
88
0.060
 Why?
DNA, Complementary
1
2006
266
0.060
 Why?
Prognosis
5
2017
3772
0.060
 Why?
Mice, Inbred C57BL
2
2007
5468
0.060
 Why?
Lymphatic Metastasis
2
2003
319
0.060
 Why?
Gene Expression Regulation, Neoplastic
3
2009
1327
0.060
 Why?
Oxidative Stress
1
2012
1261
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1559
0.060
 Why?
Biomarkers
2
2017
3968
0.060
 Why?
Collagen
1
2007
436
0.060
 Why?
Adult
7
2024
35505
0.060
 Why?
Case-Control Studies
1
2012
3383
0.060
 Why?
Survival Analysis
2
2005
1270
0.060
 Why?
Flavonoids
1
2004
76
0.060
 Why?
Organ Culture Techniques
1
2004
155
0.060
 Why?
Pruritus
1
2024
58
0.050
 Why?
Inhibitory Concentration 50
1
2004
86
0.050
 Why?
Flow Cytometry
1
2008
1158
0.050
 Why?
Protein Processing, Post-Translational
1
2006
456
0.050
 Why?
Exanthema
1
2024
74
0.050
 Why?
Eczema
1
2024
67
0.050
 Why?
Biopsy, Fine-Needle
1
2003
67
0.050
 Why?
Psoriasis
1
2024
87
0.050
 Why?
Apoptosis
2
2013
2488
0.050
 Why?
Drug Combinations
1
2004
329
0.050
 Why?
Predictive Value of Tests
3
2005
1950
0.050
 Why?
DNA Methylation
1
2008
606
0.050
 Why?
Kinetics
1
2006
1641
0.050
 Why?
Janus Kinase 3
1
2002
18
0.050
 Why?
Base Sequence
1
2006
2138
0.050
 Why?
Janus Kinase 1
1
2002
24
0.050
 Why?
STAT6 Transcription Factor
1
2002
26
0.050
 Why?
Iowa
1
2002
24
0.050
 Why?
Histoplasmosis
1
2002
14
0.050
 Why?
Lymph Nodes
2
2002
471
0.050
 Why?
STAT5 Transcription Factor
1
2002
48
0.050
 Why?
Endosonography
1
2003
141
0.050
 Why?
Antineoplastic Agents
2
2005
2044
0.050
 Why?
Prospective Studies
3
2022
7150
0.050
 Why?
Carcinoembryonic Antigen
1
2002
38
0.050
 Why?
Cell Polarity
1
2003
137
0.050
 Why?
Heart Defects, Congenital
1
2009
796
0.050
 Why?
Genes, p53
1
2002
70
0.050
 Why?
Tyrosine
1
2002
222
0.050
 Why?
Biopsy
3
2016
1087
0.040
 Why?
Inflammation
1
2012
2741
0.040
 Why?
Neoplasm Metastasis
1
2003
609
0.040
 Why?
Protein Transport
1
2002
428
0.040
 Why?
United States
2
2022
13865
0.040
 Why?
Fatigue
1
2022
319
0.040
 Why?
Steroids
1
2021
158
0.040
 Why?
Biomarkers, Tumor
1
2006
1159
0.040
 Why?
Drug Resistance, Neoplasm
3
2014
751
0.040
 Why?
Mice, Transgenic
1
2005
2135
0.040
 Why?
Skin
1
2024
724
0.040
 Why?
Cell Nucleus
1
2002
589
0.040
 Why?
Immunologic Factors
1
2021
229
0.040
 Why?
Diagnosis, Differential
1
2002
1422
0.040
 Why?
DNA
1
2004
1400
0.040
 Why?
Sensitivity and Specificity
1
2002
1842
0.030
 Why?
Retrospective Studies
1
2015
14532
0.030
 Why?
Lymphocyte Count
1
2017
148
0.030
 Why?
Antigen-Presenting Cells
1
2017
151
0.030
 Why?
Immunophenotyping
1
2017
310
0.030
 Why?
Disease Progression
2
2016
2628
0.030
 Why?
Prevalence
1
2002
2561
0.030
 Why?
Aniline Compounds
1
2014
97
0.030
 Why?
Tumor Microenvironment
1
2017
627
0.030
 Why?
Lymphocyte Activation
1
2017
1109
0.030
 Why?
Immunoenzyme Techniques
1
2013
211
0.030
 Why?
Nitriles
1
2014
169
0.030
 Why?
Quinolines
1
2014
156
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2013
328
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2013
259
0.020
 Why?
Protein Kinases
1
2014
314
0.020
 Why?
Mice, Nude
1
2013
677
0.020
 Why?
Pregnancy
1
2004
6412
0.020
 Why?
Sequence Analysis, RNA
1
2014
426
0.020
 Why?
Chronic Disease
1
2016
1722
0.020
 Why?
Communication
1
2016
843
0.020
 Why?
Computational Biology
1
2014
591
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2009
83
0.020
 Why?
Immunoprecipitation
1
2009
154
0.020
 Why?
Angiography
1
2009
197
0.020
 Why?
Fatal Outcome
1
2009
300
0.020
 Why?
Plasmids
1
2009
354
0.020
 Why?
Immunohistochemistry
2
2003
1684
0.020
 Why?
Registries
1
2016
1902
0.020
 Why?
Cyclin-Dependent Kinase 4
1
2007
44
0.020
 Why?
Up-Regulation
1
2009
832
0.020
 Why?
Structure-Activity Relationship
1
2007
548
0.020
 Why?
Echocardiography
1
2009
635
0.020
 Why?
Mediastinoscopy
1
2005
5
0.010
 Why?
Polymerase Chain Reaction
1
2008
1031
0.010
 Why?
Trastuzumab
1
2005
100
0.010
 Why?
Kaplan-Meier Estimate
1
2006
850
0.010
 Why?
Transcription, Genetic
1
2009
1416
0.010
 Why?
Electric Conductivity
1
2003
94
0.010
 Why?
Multivariate Analysis
1
2006
1491
0.010
 Why?
Infant
1
2016
9005
0.010
 Why?
Hypoxia
1
2009
1081
0.010
 Why?
Immunoassay
1
2002
108
0.010
 Why?
Trachea
1
2003
230
0.010
 Why?
Ligands
1
2003
619
0.010
 Why?
Risk Assessment
1
2009
3255
0.010
 Why?
Antibodies, Monoclonal, Humanized
1
2005
755
0.010
 Why?
Rats, Sprague-Dawley
1
2003
2393
0.010
 Why?
Calcium
1
2003
1208
0.010
 Why?
Wounds and Injuries
1
2003
711
0.010
 Why?
Rats
1
2003
5470
0.010
 Why?
Kern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (290) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)